Psilocybin assisted therapy

COMBINATION_PRODUCT2 trials

Sponsors

King's College London, University of New Mexico

Conditions

Suicidal IdeationTreatment Resistant Depression

Phase 2

Psilocybin in Depression Resistant to Standard Treatments

CompletedNCT04959253

King's College LondonTreatment Resistant Depression

Start: 2021-06-21End: 2024-12-18Updated: 2026-08-28

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

WithdrawnNCT07484906

University of New MexicoSuicidal Ideation

Start: 2026-05-01End: 2029-08-31Updated: 2026-03-20

Related Papers

Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial

BMJ Open2021-12-0119 citations